0001209191-21-008899.txt : 20210209 0001209191-21-008899.hdr.sgml : 20210209 20210209172249 ACCESSION NUMBER: 0001209191-21-008899 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210209 FILED AS OF DATE: 20210209 DATE AS OF CHANGE: 20210209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jorgensen Nathan D. CENTRAL INDEX KEY: 0001842523 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39979 FILM NUMBER: 21607939 MAIL ADDRESS: STREET 1: C/O VOR BIOPHARMA INC. STREET 2: 100 CAMBRIDGEPARK DRIVE, SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vor Biopharma Inc. CENTRAL INDEX KEY: 0001817229 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 430 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-655-6580 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 430 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-09 0 0001817229 Vor Biopharma Inc. VOR 0001842523 Jorgensen Nathan D. C/O VOR BIOPHARMA INC. 100 CAMBRIDGEPARK DRIVE, SUITE 400 CAMBRIDGE MA 02140 0 1 0 0 Chief Financial Officer Common Stock 2021-02-09 4 C 0 3534 A 29269 D Series B Preferred Stock 2021-02-09 4 C 0 48076 0.00 D Common Stock 3534 0 D Each share of Series B Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 13.6 for-one basis, and had no expiration date. /s/ Jason Minio, Attorney-in-Fact 2021-02-09